Disclosures for "Automated Video-based Characterization of Movement Quality in a Phase III Clinical Trial of Troriluzole in Subjects with Spinocerebellar Ataxia"
-
Melissa Beiner has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Melissa Beiner has stock in Biohaven Pharmaceuticals.
-
Dr. Oikonomou has stock in Evidence2Health, LLC. The institution of Dr. Oikonomou has received research support from NHLBI (NIH). Dr. Oikonomou has received intellectual property interests from a discovery or technology relating to health care.
-
Gilbert J. L'Italien has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gilbert J. L'Italien has received stock or an ownership interest from biohaven pharmaceuticals.
-
Dr. Khera has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Evidence2Health. Dr. Khera has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Khera has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA. Dr. Khera has stock in Evidence2Health. Dr. Khera has stock in ENSIGHT-AI. The institution of Dr. Khera has received research support from NIH. The institution of Dr. Khera has received research support from Bristol Myers Squibb. The institution of Dr. Khera has received research support from Novo Nordisk. Dr. Khera has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Potashman has received personal compensation for serving as an employee of Biohaven Pharmaceuticals.
-
Dr. Schmahmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. The institution of Dr. Schmahmann has received research support from National Ataxia Foundation. The institution of Dr. Schmahmann has received research support from Biohaven. Dr. Schmahmann has received intellectual property interests from a discovery or technology relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care.
-
Dr. Perlman has nothing to disclose.
-
Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.